Public health

Winners Named in IDC Government Insights' Seventh Annual Smart Cities North America Awards

Retrieved on: 
Wednesday, March 27, 2024

IDC Government Insights today named the winners in the seventh annual Smart Cities North America Awards (SCNAA).

Key Points: 
  • IDC Government Insights today named the winners in the seventh annual Smart Cities North America Awards (SCNAA).
  • The awards were designed to recognize the progress North American states and municipalities have made in executing Smart Cities projects, as well as providing a forum for sharing best practices to help accelerate Smart City development in the region.
  • Winners will be honored at Smart Cities Connect being held May 7–10, 2024, at the Raleigh Convention Center in Raleigh, NC.
  • "We are thrilled to witness the continued dedication by government and education officials and technology partners to develop smart city initiatives for smart, sustainable outcomes."

Montana DPHHS and Netsmart Announce Successful Launch of State Solution for Electronic Visit Verification

Retrieved on: 
Tuesday, March 19, 2024

Netsmart , the industry-leading provider of software and services for payers, providers and state Medicaid Agencies, has announced the successful deployment of the Netsmart electronic visit verification ( EVV ) system for the Montana Department of Public Health & Human Services (DPHHS).

Key Points: 
  • Netsmart , the industry-leading provider of software and services for payers, providers and state Medicaid Agencies, has announced the successful deployment of the Netsmart electronic visit verification ( EVV ) system for the Montana Department of Public Health & Human Services (DPHHS).
  • As Montana’s designated aggregator, Netsmart has established an open vendor and provider model designed to support compliance and maximize provider choice and satisfaction.
  • Montana providers utilizing the Netsmart EVV solution, MobileCaregiver+, have completed more than 85,000 visits, enhancing provider experience and supporting member outcomes for more than 1,700 individuals.
  • In collaboration with DPHHS, Netsmart has provided ongoing provider and stakeholder education and training, resulting in increased adoption and provider satisfaction.

Cotchett, Pitre & McCarthy Files Lawsuit on Behalf of Residents of Maywood, CA, for Exposure to Cancer Causing Ethylene Oxide

Retrieved on: 
Monday, March 18, 2024

Cotchett, Pitre & McCarthy LLP filed a lawsuit on behalf of many longtime residents of Maywood, CA, next to Vernon, an industrial area, for their decades long exposure to cancer caused by carcinogenic Ethylene Oxide being released into the air.

Key Points: 
  • Cotchett, Pitre & McCarthy LLP filed a lawsuit on behalf of many longtime residents of Maywood, CA, next to Vernon, an industrial area, for their decades long exposure to cancer caused by carcinogenic Ethylene Oxide being released into the air.
  • Ethylene Oxide is used to sterilize medical equipment and spices but, during the process, some of the Ethylene Oxide escapes the facility into the surrounding air.
  • Ethylene Oxide is odorless and colorless, so nearby Maywood residents never knew it was in the air surrounding their homes.
  • According to the National Cancer Institute, and other protective health agencies around the world, Ethylene Oxide is associated with breast cancer, stomach cancer, lymphoma, and leukemia.

OncoOne Announces Formation of Clinical Advisory Board to Support Development of ON104 for Chronic Inflammatory Diseases

Retrieved on: 
Tuesday, March 12, 2024

OncoOne , a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the formation of a clinical advisory board to provide strategic and clinical insights for the company’s lead program in immunology, ON104.

Key Points: 
  • OncoOne , a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the formation of a clinical advisory board to provide strategic and clinical insights for the company’s lead program in immunology, ON104.
  • ON104 is a monoclonal antibody targeting the oxidized isoform of the macrophage migration inhibitory factor (oxMIF) for the treatment of chronic inflammatory diseases.
  • His research focuses on arthritis and other inflammatory rheumatic diseases, precision medicine, and the management of complex diseases.
  • Dr. Freissmuth is an inaugural member of OncoOne’s scientific advisory board, where he continues to support the development of the company’s pipeline of biotherapeutics.

Decolonizing Global Health a Must, says Pandemic Panel

Retrieved on: 
Tuesday, March 12, 2024

On March 8, during the CUGH 2024 conference , the AHF Global Public Health Institute and the University of California, Berkeley, School of Public Health convened a panel titled "Decolonizing Global Health Financing: Charting an Equitable Path Forward."

Key Points: 
  • On March 8, during the CUGH 2024 conference , the AHF Global Public Health Institute and the University of California, Berkeley, School of Public Health convened a panel titled "Decolonizing Global Health Financing: Charting an Equitable Path Forward."
  • This focused session shed light on redefining global health funding mechanisms to support pandemic prevention, preparedness, and response and reconstructing global health financing through equitable and sustainable partnerships.
  • Decolonizing global health is critical to addressing global health emergencies.
  • Regions should have the power to declare their own public health emergencies to mobilize international resources to respond to them effectively.”
    As countries negotiate to reshape the existing global health security architecture , it is vital that they adequately address decolonizing global health financing as a critical imperative.

AMERICAN SKIN ASSOCIATION ANNOUNCES NEW BOARD MEMBER JOSEPH F. MEROLA, MD, MMSc, FAAD, FACR

Retrieved on: 
Thursday, April 4, 2024

NEW YORK, April 4, 2024 /PRNewswire/ -- American Skin Association (ASA) announced today that Joseph F. Merola, MD, MMSc, FAAD, FACR, will join its Board of Directors.

Key Points: 
  • NEW YORK, April 4, 2024 /PRNewswire/ -- American Skin Association (ASA) announced today that Joseph F. Merola, MD, MMSc, FAAD, FACR, will join its Board of Directors.
  • Distinguished Chair in Dermatology and is Professor at the Peter O'Donnell Jr. School of Public Health.
  • "We are proud to announce the addition of Dr. Joseph Merola to ASA's Board of Directors.
  • He was recently elected to the Board of the American Academy of Dermatology.

Orchard Software Announces New Electronic Support for Antimicrobial Stewardship

Retrieved on: 
Thursday, April 4, 2024

CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN) , which supports regulatory requirements and antimicrobial stewardship endeavors.

Key Points: 
  • CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN) , which supports regulatory requirements and antimicrobial stewardship endeavors.
  • AUR reporting and data analysis promotes antimicrobial stewardship and impedes the transmission of resistant pathogens.
  • "At Orchard, we are continually looking for ways to support our customers and the valuable work they do.
  • Adding AUR reporting is one more way that we can provide superior support to our customers," said Billie Whitehurst, CEO of Orchard Software.

EPA Creates Historic National Green Bank; Elemental Excelerator Partners With Winning Coalitions to Deliver Climate Solutions

Retrieved on: 
Thursday, April 4, 2024

HONOLULU and SAN FRANCISCO, April 4, 2024 /PRNewswire/ -- Elemental Excelerator, a nonprofit investor focused on scaling climate technology for deep community impact, is honored to be a part of this momentous investment in American innovation and communities by the Environmental Protection Agency (EPA). Elemental plans to collaborate with all three national winners, serving as a national investment partner and sub-awardee of the Coalition for Green Capital (CGC), a transaction partner of Climate United and a supporting partner to Power Forward Communities. In addition to announcing the winners of the $14 billion National Clean Investment Fund, the EPA announced Justice Climate Fund, also an Elemental partner, as one of the winners of the $6 billion Clean Communities Investment Accelerator. Now that the EPA has announced these awards, Elemental will complete the contracting process with deployment of funds expected in the summer. This EPA program is a significant policy achievement that will help the U.S. reach its goals to cut greenhouse gas emissions in half by 2030 and reach net-zero emissions by 2050. 

Key Points: 
  • Elemental plans to collaborate with all three national winners, serving as a national investment partner and sub-awardee of the Coalition for Green Capital (CGC), a transaction partner of Climate United and a supporting partner to Power Forward Communities.
  • Now that the EPA has announced these awards, Elemental will complete the contracting process with deployment of funds expected in the summer.
  • We are honored to partner with coalition members to mobilize private capital and deliver on this vision," said Dawn Lippert, Founder & CEO of Elemental Excelerator.
  • Through our work with Elemental Excelerator, these funds will rapidly accelerate infrastructure, affordability and the cleaning of the air in our communities.

Cadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of Directors

Retrieved on: 
Thursday, April 4, 2024

He also serves on the board of directors of Athira Pharma, Inc., a neurology-focused clinical-stage biopharmaceutical company.

Key Points: 
  • He also serves on the board of directors of Athira Pharma, Inc., a neurology-focused clinical-stage biopharmaceutical company.
  • "We are delighted to welcome Dr. Panzara to our board of directors," said Dr. Carol Curtis, chief executive officer of Cadenza Bio.
  • "His extensive experience in developing therapies for MS and other neurological disorders aligns perfectly with our mission at Cadenza Bio.
  • "I look forward to joining the board of directors at Cadenza Bio at such an exciting time in the growth of the company," said Dr. Panzara.

Illinois Launches New "Pause to Heal" Firearm Restraining Order Education Campaign

Retrieved on: 
Tuesday, April 2, 2024

CHICAGO, April 2, 2024 /PRNewswire/ -- A new partnership to raise awareness about the lifesaving potential of Firearm Restraining Orders (FROs), or "red flag laws," is launching today during National Public Health Week involving the Illinois Department of Public Health (IDPH), Brady: United Against Gun Violence, and the Ad Council.

Key Points: 
  • The Illinois effort is the first phase of a planned multi-state campaign called "Pause to Heal."
  • "The State of Illinois is fortunate to partner with Brady and the Ad Council to launch a one-of-a-kind public health campaign educating the public on the importance of firearm restraining orders.
  • "Illinois has two very effective tools, the Firearm Restraining Order and Clear and Present Danger reporting.
  • "A Firearm Restraining Order gives a person in crisis time to heal," says one billboard.